News on Inferior_Colliculus from BioPortfolio.com http://www.BioPortfolio.com Consolidated Inferior_Colliculus news from BioPortfolio.com Tue, 09 Feb 2010 22:42:09 GMT en Dynavax Initiates Large-Scale Phase 3 Trial Of HEPLISAVTMhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036267&HITNO=0&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036267&THISHREF=http://c.moreover.com/click/here.pl%3fz2536544045%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036267&HITNO=0&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036267&THISHREF=http://c.moreover.com/click/here.pl%3fz2536544045%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: A Cost-Effectiveness Analysis of Three Treatments for Age-Related Macular Degenerationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034966&HITNO=1&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034966&THISHREF=http://c.moreover.com/click/here.pl%3fz2536070711%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034966&HITNO=1&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034966&THISHREF=http://c.moreover.com/click/here.pl%3fz2536070711%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Microfracture for chondral defects of the talus: maintenance of early results at midterm follow-uphttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034238&HITNO=2&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034238&THISHREF=http://c.moreover.com/click/here.pl%3fz2535686330%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034238&HITNO=2&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034238&THISHREF=http://c.moreover.com/click/here.pl%3fz2535686330%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: The prognostic value of panoramic radiography of inferior alveolar nerve damage after mandibular third molar removal: retrospective study of 400 caseshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034187&HITNO=3&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034187&THISHREF=http://c.moreover.com/click/here.pl%3fz2535674376%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034187&HITNO=3&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034187&THISHREF=http://c.moreover.com/click/here.pl%3fz2535674376%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033449&HITNO=4&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033449&THISHREF=http://c.moreover.com/click/here.pl%3fz2535208391%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033449&HITNO=4&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033449&THISHREF=http://c.moreover.com/click/here.pl%3fz2535208391%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Inferior vena cava collapsibility to guide fluid removal in slow continuous ultrafiltration: a pilot studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028844&HITNO=5&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028844&THISHREF=http://c.moreover.com/click/here.pl%3fz2532868323%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028844&HITNO=5&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028844&THISHREF=http://c.moreover.com/click/here.pl%3fz2532868323%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Hypofractionated radiation led to better quality of life in breast cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031646&HITNO=6&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031646&THISHREF=http://c.moreover.com/click/here.pl%3fz2534290943%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031646&HITNO=6&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031646&THISHREF=http://c.moreover.com/click/here.pl%3fz2534290943%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHemonctoday: Hypofractionated radiation led to better quality of life in breast cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031645&HITNO=7&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031645&THISHREF=http://c.moreover.com/click/here.pl%3fz2534290763%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031645&HITNO=7&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031645&THISHREF=http://c.moreover.com/click/here.pl%3fz2534290763%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHemonctoday: Dynavax Initiates Large-Scale Phase 3 Trial of HEPLISAV(TM)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031540&HITNO=8&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031540&THISHREF=http://c.moreover.com/click/here.pl%3fz2534256470%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031540&HITNO=8&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031540&THISHREF=http://c.moreover.com/click/here.pl%3fz2534256470%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Daiichi Sankyo: new influenza drug may boost flagging Japanese markethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026833&HITNO=9&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026833&THISHREF=http://c.moreover.com/click/here.pl%3fz2531375807%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026833&HITNO=9&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026833&THISHREF=http://c.moreover.com/click/here.pl%3fz2531375807%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: Optimer Pharmaceuticals Announces Positive Results From Second Fidaxomicin Phase 3 Study in Patients With Closhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026069&HITNO=10&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026069&THISHREF=http://c.moreover.com/click/here.pl%3fz2530334491%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4026069&HITNO=10&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4026069&THISHREF=http://c.moreover.com/click/here.pl%3fz2530334491%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Simultaneous 3D Assessment of Glenohumeral Shape, Humeral Head Centering, and Scapular Positioning in Atraumathttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024607&HITNO=11&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024607&THISHREF=http://c.moreover.com/click/here.pl%3fz2529007434%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024607&HITNO=11&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024607&THISHREF=http://c.moreover.com/click/here.pl%3fz2529007434%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAmerican Journal of Sports Medicine: Optimer reports positive results from second Phase III study of antibiotic drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023922&HITNO=12&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023922&THISHREF=http://c.moreover.com/click/here.pl%3fz2528488693%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023922&HITNO=12&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023922&THISHREF=http://c.moreover.com/click/here.pl%3fz2528488693%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Reducing antibiotic exposure in ICU:http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018576&HITNO=13&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018576&THISHREF=http://c.moreover.com/click/here.pl%3fz2525784845%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4018576&HITNO=13&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4018576&THISHREF=http://c.moreover.com/click/here.pl%3fz2525784845%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comLancet: Renal Pelvic Cancer with Tumor Thrombus in the Vena Cava Inferiorhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023780&HITNO=14&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023780&THISHREF=http://c.moreover.com/click/here.pl%3fz2528397228%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4023780&HITNO=14&MSIZE=299&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Inferior_Colliculus&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4023780&THISHREF=http://c.moreover.com/click/here.pl%3fz2528397228%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comUrologia Internationalis: